PharmaFacts for Case Managers - September 2026
Brought to you by the publishers of CareManagement
Read a summary of the essential prescribing information for new FDA-approved drugs in the September issue of PharmaFacts.New drugs include:
Read a summary of the essential prescribing information for new FDA-approved drugs and devices in the September issue of PharmaFacts. New drugs/devices include:
•Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System
•Mimrylo Lyophilized Powder for Injection for polycythemia vera
•Bixlenvo Tablets for HIV-1 infection
•Lisraya Tablets for dermatomyositis
•Rasonque Tablets for pancreatic cancer
•Pasatru Injection for fibrodysplasias ossificans progressiva
•Genglycos Suspension for Intravenous Infusion for glycogen storage disease type la
•Zenbexus Capsules for multiple myeloma
•Tudriqev Suspension for Intratumor Injection for advanced cutaneous melanoma
•Orzeyful Tablets for narcolepsy type 1
•mFlusiva Injection for flu
Trusted by certified case managers and certified disability management specialists nationwide.
Stay Current.Stay Certified.Join ACCM.
If you are a CCM or CDMS, and you want to stay on the forefront of your practice, plus fulfill your CE requirements on your time and in your space, then ACCM is for you. Join your colleagues today.